Area of research
Genetics · Reproductive Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, and Cervical Cancer and HPV Research.
Transgelin 2 guards T cell lipid metabolism and antitumour function
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
Uptake of Cascade Genetic Testing for Hereditary Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
Web-based tool for cancer family history collection: A prospective randomized controlled trial
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis
Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center
Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer
Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling
Promoting health equity in the era of COVID-19
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and <i>MLH1</i> methylation improved the diagnosis of Lynch syndrome across the population?
TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma
Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma
Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology